PANACEABIONSEPanacea Biotec Limited· PharmaceuticalsMediumNeutral
Announced Mon, 15 Dec · 18:39 IST

Panacea Biotec Limited has informed the Exchange regarding Appointment of Mr. Ankit Jain as Company Secretary & Compliance Officer of the company w.e.f. December 16, 2025.

Management Changes View source PDF

PANACEABIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Panacea Biotec Limited has announced the appointment of Mr. Ankit Jain as the Company Secretary and Compliance Officer of the company, effective December 16, 2025. This is a key managerial personnel (KMP) appointment responsible for ensuring the company meets its regulatory and listing obligations. No further details about his background or the previous incumbent were disclosed in the filing.

Likely market impact

This is a routine compliance appointment and unlikely to have a direct impact on the stock price. Shareholders should note that the company has filled a critical governance role on a defined timeline.